Intermediates useful in the preparation of diaminothiazoles
AssigneeHoffmann-La Roche Inc.
InventorsQingjie Ding, Paul Gillespie, Kyungjin Kim, Warren William McComas, Agostino Perrotta
Life of this patent
Estimating the term…
Abstract
Disclosed are novel diaminothiazoles that are selective inhibitors of Cdk4. These compounds and their pharmaceutically acceptable salts and esters are anti-proliferative agents useful in the treatment or control of solid tumors, in particular breast, colon, lung and prostate tumors. Also disclosed are pharmaceutical compositions containing these compounds as well as intermediates useful in the preparation of the compounds.
Claims3
The compound 1-(4-isothiocyanatophenyl)-4-(1-methylethyl) piperazine.
The compound 4-(2-hydroxyethyl)-1-(4-isothiocyanatophenyl) piperazine.
A compound selected from the group consisting of:
- 1-(2-Fluoro-4-isothiocyanatophenyl)-4-methylpiperazine,
- 1-(1-Methylethyl)-4-(4-nitrophenylpiperazine),
- 4-[4-(1-Methylethyl)-1-piperazinyl]benzenamine,
- 1-(4-Isothiocyanatophenyl)-4-(1-methylethyl)piperazine,
- 4-(2-Hydroxyethyl)-1-(4-isothiocyanatophenyl)piperazine,
- 1-(4-Isothiocyanatophenyl)-4-(2-methoxy-ethyl)piperazine,
- 1-(4-Isothiocyanatophenyl)-4-(1-methylpropyl)piperazine,
- 4-Cyclopentyl-1-(4-isothiocyanatophenyl)piperazine,
- 1-(4-Isothiocyanatophenyl)-4-(2-methylpropyl)piperazine, and
- 4-(3-Hydroxypropyl)-1-(4-isothiocyanatophenyl)piperazine.
Dependencies are inferred from the claim text.